| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 01/25/2012 | CN101411737B Safflower injection formulation and preparation method thereof |
| 01/25/2012 | CN101347528B Chinese medicinal composition for resisting cardiovascular and cerebrovascular diseases |
| 01/25/2012 | CN101269049B Phosphoric acid ligustrazine micropore permeation pump control-release tablet and preparation method thereof |
| 01/25/2012 | CN101244122B Pharmaceutical combination |
| 01/24/2012 | USRE43140 Immunoregulator |
| 01/24/2012 | US8101793 Retinoid derivatives with antiangiogenic, antitumoral and proapoptotic activities |
| 01/24/2012 | US8101650 Method for treating a immunology-related disease |
| 01/24/2012 | US8101649 N-acylhydrazone derivatives useful as modulators of nicotinic acetylcholine receptors |
| 01/24/2012 | US8101612 N-3-isoxazolyl-4-methyl-3-(1-((1-methylethyl)oxy)-6-phthalazinyl)benzamide; p38 kinase inhibitor; antiinflammatory, analgesic agent; rheumatoid arthritis, osteoporosis, leukemia, psoriasis, Crohn's disease, rhinitis, ulcerative colitis, dermatitis, asthma, Alzheimer's disease, type I and II diabetes |
| 01/24/2012 | US8101599 Pharmaceutical composition containing anti-hypertensive agents |
| 01/24/2012 | US8101363 Obtaining a level of a marker of systemic inflammation in individual, comparing level of marker to a predetermined value specific for diagnosis of diabetes or diabetic complications, and characterizing the individual's risk profile |
| 01/24/2012 | US8101188 Methods for the modulation of neovascularization and/or the growth of collateral arteries and/or other arteries from preexisting arteriolar connections |
| 01/24/2012 | CA2656216C Compounds, compositions and methods for preventing neurodegeneration in acute and chronic injuries in the central nervous system |
| 01/24/2012 | CA2579810C Stable pharmaceutical compositions of 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide |
| 01/24/2012 | CA2537832C Nonsedating a-2 agonist 1-(2,3-dimethyl-phenyl)-ethyl-1, 3-dihydro-imizadole-2-thione |
| 01/24/2012 | CA2522594C Mitotic kinesin inhibitor |
| 01/24/2012 | CA2520436C Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof |
| 01/24/2012 | CA2509159C Isophthalic acid derivatives |
| 01/24/2012 | CA2498559C Indole derivatives or benzimidazole derivatives for modulating i.kappa.b kinase |
| 01/24/2012 | CA2493644C Composition for promoting the proliferation of lactobacillus casei subsp. casei |
| 01/24/2012 | CA2462857C Angiotensin peptide-carrier conjugates and uses thereof |
| 01/24/2012 | CA2459577C An enantiomerically pure opioid diarylmethylpiperazine and methods of using same |
| 01/24/2012 | CA2455483C The use of trifluoroacetylalkyl-substituted phenyl, phenol and benzoyl derivatives in the treatment and/or prophylaxis of obesity and its concomitant and/or secondary diseases |
| 01/24/2012 | CA2455227C Use of biologically active hiv-1 tat, fragments or derivates thereof, to target and/or to activate antigen-presenting cells, and/or to deliver cargo molecules for preventive or therapeutic vaccination and/or to treat other diseases |
| 01/24/2012 | CA2435687C Omega-aminoalkylamides of r-2-aryl-propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cells |
| 01/24/2012 | CA2406168C Polyamide nucleic acid derivatives, agents and methods for producing same |
| 01/24/2012 | CA2402092C 1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases |
| 01/24/2012 | CA2394327C Substituted piperazine and piperidine calcium channel blockers |
| 01/24/2012 | CA2383174C Method of treating cardio pulmonary diseases with no group compounds |
| 01/24/2012 | CA2344317C Use of compounds that reduce alpha2-antiplasmin in vivo for the preparation of a composition for the treatment of ischemic stroke |
| 01/24/2012 | CA2221318C High affinity oligonucleotide ligands to growth factors |
| 01/20/2012 | CA2735631A1 Curcumin formulations and methods for making such formulations |
| 01/19/2012 | WO2012009471A1 Anti-angiogenic agent and method of using such agent |
| 01/19/2012 | WO2012009447A2 THE cAMP/PKA/HDAC5 PATHWAY AND USES THEREOF |
| 01/19/2012 | WO2012008764A2 Composition for inducing multiple nuclear division of cells |
| 01/19/2012 | WO2012008549A1 Heterocyclic ring compound |
| 01/19/2012 | WO2012008474A1 Fructose absorption inhibitor |
| 01/19/2012 | WO2012008435A1 Biaryl amide derivative or pharmaceutically acceptable salt thereof |
| 01/19/2012 | WO2012007777A1 Novel proteins, process for preparation thereof, and use thereof |
| 01/19/2012 | WO2012007562A1 Cyclotetrapeptides with pro-angiogenic properties |
| 01/19/2012 | WO2012007539A1 Ip receptor agonist heterocyclic compounds |
| 01/19/2012 | WO2012007327A1 Wogonin for the prevention and therapy of cardiac hypertrophy |
| 01/19/2012 | WO2012006960A1 NOVEL FUSED HETEROCYCLIC DERIVATIVES USEFUL AS c-MET TYROSINE KINASE INHIBITORS |
| 01/19/2012 | WO2012006958A1 Amids substituted indazole derivativees as ploy(adp-ribose)polymerase inhibitors |
| 01/19/2012 | WO2012006953A1 Oxazine derivatives and their use in the treatment of neurological disorders |
| 01/19/2012 | WO2012006938A1 Pharmaceutical composition capable of targeted release of trace element, and preparation method and application of pharmaceutical composition |
| 01/19/2012 | WO2012006864A1 Triterpenoid saponin compounds, preparation methods and uses thereof |
| 01/19/2012 | WO2011137319A3 Stabilized fibronectin domain compositions, methods and uses |
| 01/19/2012 | WO2011132051A3 Tricycle compounds as phosphodiesterase-10 inhibitors |
| 01/19/2012 | WO2011109679A3 Inhibitors of 5-lipoxygenase |
| 01/19/2012 | WO2011087491A9 Parstatin peptides and uses thereof |
| 01/19/2012 | US20120016035 Synergistic combinations comprising a renin inhibitor for cardiovascular diseases |
| 01/19/2012 | US20120016020 Solid dispersion of alpha-ketoamide derivatives |
| 01/19/2012 | US20120016018 Composition for inducing multiple nuclear division of cells |
| 01/19/2012 | US20120016016 Methods and compositions for treating complications of diabetes and vascular diseases using flavones |
| 01/19/2012 | US20120016009 Optimized Methods For Delivery Of DSRNA Targeting The PCSK9 Gene |
| 01/19/2012 | US20120015998 Phototherapy methods and devices comprising emissive aryl-heteroaryl compounds |
| 01/19/2012 | US20120015991 Polycyclic antagonists of lysophosphatidic acid receptors |
| 01/19/2012 | US20120015988 Sulfone Compounds Which Modulate The CB2 Receptor |
| 01/19/2012 | US20120015985 Methods of Administering Pirfenidone Therapy |
| 01/19/2012 | US20120015984 Granulate Formulation of Pirfenidone and Pharmaceutically Acceptable Excipients |
| 01/19/2012 | US20120015978 Therapeutic agents for ocular hypertension |
| 01/19/2012 | US20120015977 Quinolinone derivatives useful for the treatment of cns disorders |
| 01/19/2012 | US20120015976 Autotaxin inhibitors |
| 01/19/2012 | US20120015970 New azacyclic compounds |
| 01/19/2012 | US20120015968 Use of pyrimidylaminobenzamide derivatives for the treatment of disorders mediated by the leucine zipper-and sterile alpha motif-containing kinase (zak) |
| 01/19/2012 | US20120015966 Ppar active compounds |
| 01/19/2012 | US20120015958 1-(4-ureidobenzoyl)piperazine derivatives |
| 01/19/2012 | US20120015957 Piperazinyl derivatives useful as modulators of the neuropeptide y2 receptor |
| 01/19/2012 | US20120015952 Inhibitors of NF-KB |
| 01/19/2012 | US20120015950 Carbamate derivatives of alkyl-heterocycles, preparation thereof and therapeutic use thereof |
| 01/19/2012 | US20120015949 Composition and method of decreasing renal ischemic damage |
| 01/19/2012 | US20120015937 Kinase Inhibitors And Their Uses |
| 01/19/2012 | US20120015931 Purine compounds selective for pi3k p110 delta, and methods of use |
| 01/19/2012 | US20120015929 Novel compounds as cannabinoid receptor ligands |
| 01/19/2012 | US20120015928 Amido Compounds And Their Use As Pharmaceuticals |
| 01/19/2012 | US20120015925 Novel benzothiazepine and benzothiepine compounds |
| 01/19/2012 | US20120015920 Heterobicyclic metalloprotease inhibitors |
| 01/19/2012 | US20120015909 Mao-b inhibitors useful for treating obesity |
| 01/19/2012 | US20120015905 Compounds for the prevention and treatment of cardiovascular diseases |
| 01/19/2012 | US20120015904 Biomarkers for diagnosis of transient ischemic attacks |
| 01/19/2012 | US20120015876 Conjugates of glp-1 agonists and uses thereof |
| 01/19/2012 | US20120015868 Metastin derivatives and use thereof |
| 01/19/2012 | US20120015032 Combination preparation comprising inhibitor of hmg-coa reductase and aspirin and method for manufacturing the same |
| 01/19/2012 | US20120015029 Direct compression formulation and process |
| 01/19/2012 | US20120015024 Methods for treating tweak-related conditions |
| 01/19/2012 | US20120015019 Drug Coated Balloon With In-Situ Formed Drug Containing Microspheres |
| 01/19/2012 | US20120014979 Use of bcl6 inhibitors for treating autoimmune diseases |
| 01/19/2012 | US20120014974 Methods of modulating cell death based on the bit1/aes regulatory pathway |
| 01/19/2012 | US20120014967 Il-1beta binding antibodies and fragments thereof |
| 01/19/2012 | US20120014962 Method of inhibiting fibrogenesis and treating fibrotic disease |
| 01/19/2012 | US20120014958 Stable and soluble antibodies inhibiting vegf |
| 01/19/2012 | US20120014954 Sparc binding scfvs |
| 01/19/2012 | US20120014951 Pcsk9 antagonists |
| 01/19/2012 | US20120014938 Angiogenic Tyrosyl t-RNA Synthetase Compositions and Methods |
| 01/19/2012 | US20120014937 Human Beta-Adrenergic receptor kinase polypeptide and methods |
| 01/19/2012 | US20120014924 Compositions and Methods for Improving the Functional Efficacy of Stem Cell-Derived Cardiomyocytes |
| 01/19/2012 | US20120014921 Treatment of stroke and other acute neural degenerative disorders via intranasal administration of umbilical cord-derived cells |
| 01/19/2012 | US20120014920 Annexin and its use to treat inflammatory disorders |
| 01/19/2012 | US20120014907 Use of substituted cyanopyrrolidines and combination preparations containing them for treating hyperlipidemia and associated diseases |